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Background: The male brain is putatively organised early in development by testosterone, with the sexually
dimorphic nucleus of the medial preoptic area (SDN) a main exemplifier of this. However, pubescent neurogenesis
occurs in the rat SDN, and the immature testes secrete anti-Müllerian hormone (AMH) as well as testosterone. We
have therefore re-examined the development of the murine SDN to determine whether it is influenced by AMH
and/or whether the number of calbindin-positive (calbindin+ve) neurons in it changes after pre-pubescent
development.
Methods: In mice, the SDN nucleus is defined by calbindin+ve neurons (CALB-SDN). The number and size of the
neurons in the CALB-SDN of male and female AMH null mutant (Amh−/−) mice and their wild-type littermates
(Amh+/+) were studied using stereological techniques. Groups of mice were examined immediately before the
onset of puberty (20 days postnatal) and at adulthood (129–147 days old).
Results: The wild-type pre-pubertal male mice had 47% more calbindin+ve neurons in the CALB-SDN than their
female wild-type littermates. This sex difference was entirely absent in Amh−/− mice. In adults, the extent of sexual
dimorphism almost doubled due to a net reduction in the number and size of calbindin+ve neurons in females and
a net increase in neuron number in males. These changes occurred to a similar extent in the Amh−/− and Amh+/+
mice. Consequently, the number of calbindin+ve neurons in Amh−/− adult male mice was intermediate between
Amh+/+ males and Amh+/+ females. The sex difference in the size of the neurons was predominantly generated by
a female-specific atrophy after 20 days, independent of AMH.
Conclusions: The establishment of dimorphic cell number in the CALB-SDN of mice is biphasic, with each phase
being subject to different regulation. The second phase of dimorphism is not dependent on the first phase having
occurred as it was present in the Amh−/− male mice that have female-like numbers of calbindin+ve neurons at 20
days. These observations extend emerging evidence that the organisation of highly dimorphic neuronal networks
changes during puberty or afterwards. They also raise the possibility that cellular events attributed to the imprinting
effects of testosterone are mediated by AMH.
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The sexually dimorphic structures in the brain are gen-
erally considered to form early in development, with the
role of pubescent hormones limited to activation and re-
finement of existing neuronal networks [1-3]. However,
this concept dates from an era when remodelling of the
postnatal brain was thought impossible. Consequently,
most historic experiments relating to the control of neuron
number have endpoints before puberty and would therefore
not detect a pubescent change in cell number. Pubescent
neurogenesis [4] and pubescent loss of cortical neurons [5]
have recently been reported in rodents, creating a rationale
to reassess when cell number is established in the highly
dimorphic brain nuclei. We report here that the number of
calbindin-positive (calbindin+ve) neurons in the sexually di-
morphic nucleus of the medial preoptic area (CALB-SDN)
of mice is dimorphic before puberty but with the extent of
dimorphism subsequently doubling during or after puberty.
The immature testes produce anti-Müllerian hormone
(AMH, also known as MIS) as well as testosterone. The role
of AMH as a regulator of sexual differentiation is also chan-
ging. Historically, it was thought to have a single function,
to initiate the regression of the uterus in male embryos [6].
However, AMH and its unique type 2 receptor are highly
conserved genes and predate the evolution of the uterus [7].
In some teleost species (a class of ray-finned fish), AMH
appears to determine sex [7,8]. These observations raise
the possibility that AMH has a broader role in virilisation
than previously suspected.
Contemporary studies of mice point to the brain as a
site of gonadal AMH action. The immature testes of
humans, rodents and other mammals continuously secrete
high levels of AMH during embryonic and postnatal devel-
opment until puberty, at which stage AMH levels in males
decline rapidly. In men and adult male mice, plasma AMH
levels are typically less than 5% of the levels during develop-
ment [6,9-11]. Ovarian production of AMH, in contrast,
begins as females enter puberty, with the consequence that
young male and female adults have similar levels of AMH
[11-13]. The AMH in blood is entirely derived from the go-
nads [10,14]. AMH receptors are ubiquitously expressed in
developing murine neurons [14], with AMH being required
for the male exploratory behaviour [14,15] and the male
bias in the number of cerebellar Purkinje and spinal motor
neurons [14,16,17]. The spinal bulbocavernosus neurons, in
contrast, develop independently of AMH [14]. We report
here that the initial sexual dimorphism in the number of
neurons in the CALB-SDN is absent in Amh−/− mice.
Methods
Animals
C57BL/6 Amh−/− and Amh+/+ mice were littermates gener-
ated from Amh+/− parents [18,19] (The Jackson Laboratory,
Bar Harbor, ME, USA) and were housed as previouslydescribed [20]. The Animal Ethics Committee of the
University of Otago approved all experiments.
Age-matched pre-pubertal (20 days old) and adult
(129–147 days old) mice of both sexes were used in this
study, with the adult female mice collected at a random
stage of the estrous cycle. Six mice were analysed for
each group. The mice were anaesthetized with ketamine
(225 mg/kg) and Domitor (3 mg/kg) and transcardially
perfused with 4% paraformaldehyde in 0.1 M phosphate
buffer (PB), pH 7.4, using a peristaltic pump (adults,
13.3 ml/min; 20 days, 10.0 ml/min) over 3 min. The brains
were incubated in the same fixative for 2 h at room
temperature (RT), followed by 36 h in 4% paraformalde-
hyde containing 15% sucrose at 4°C and then overnight at
4°C in 30% sucrose in 0.01 M PB, pH 7.4. They were then
embedded in Tissue-Tek (Sakura Finetek USA, Torrance,
CA, USA), frozen on dry ice and stored at −80°C. A notch
was made in the cortex of the right-hand side to enable a
consistent side of the brain to be studied.
Immunohistochemistry
The brain region containing the CALB-SDN was serially
sectioned at a thickness of 20 μm in a cryostat, and every
third section was immediately stained with an anti-
calbindin antibody (C9848, Sigma Aldrich, St. Louis, MO,
USA). The sections were stained by free-floating immuno-
histochemistry. Each section was incubated in a 30 mM
sodium citrate buffer, pH 8.7, for 10 min at 80°C using a
water bath to heat the incubation chamber. The sections
were then cooled at RT for 20 min, washed twice with 0.1
M glycine in PB (0.01 M PB, pH 7.2) for 5 min and then
blocked in 5% donkey serum (Jackson ImmunoResearch,
West Grove, PA, USA) for 1 h at RT. The sections were
then incubated in 1.85 μg/ml of mouse monoclonal anti-
calbindin-D28k for 18 h at 4°C with gentle vibration. Other
sections were incubated in control IgG. The sections
were washed six times in washing buffer (0.01 M PB, pH
7.2, 2% NaCl, 0.1% Tween-20) for 5 min, incubated in 2
μg/ml of biotinylated donkey anti-mouse IgG (Jackson
ImmunoResearch) for 1.5 h at RT and washed three
times for 5 min, followed by an incubation in 1% H2O2
for 10 min to inactivate endogenous peroxidases. Sections
were then washed three times in PB for 5 min, incubated
with biotin/peroxidase-conjugated streptavidin amplifica-
tion complex (1:200, Amersham Biosciences/GE Healthcare
Ltd, Auckland, New Zealand) for 1.5 h at RT, washed three
times in PB for 5 min and once in 0.1 M acetate buffer, pH
5.2, for 5 min, stained with AEC (3-amino-9-ethylcarbazole,
Sigma-Aldrich) substrate for 12 min and mounted on
gelatine-coated microscopy slides.
Anatomy
The sexually dimorphic nucleus of the medial preoptic
area was identified by its calbindin+ve neurons (Figure 1).
Figure 1 The sexually dimorphic nucleus of the medial
preoptic area. A cryosection of an adult Amh+/+ male mouse was
stained with an antibody to calbindin. The CALB-SDN (dashed line) is
an ellipsoid-shaped cell cluster close to the third ventricle (3V)
extending in a dorsolateral direction to the anterior commissure (ac).
The scale bar represents 500 μm.
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nucleus identified by Nissl staining in rats [21]. The
calbindin+ve cluster was ellipsoidal and located 200–300 μm
lateral to the third ventricle extending in the dorsolateral
direction to the anterior commissure (Figure 1). This
distinct cluster extended between 120 and 180 μm in
the rostrocaudal direction through the medial preoptic
area. The principal nucleus of the bed nucleus of the stria
terminalis is also detectable by calbindin staining. Its most
caudal extension can appear close to the most dorsal part
of the CALB-SDN cluster, depending on the angle of
sectioning. Thus, special attention was taken to only in-
clude calbindin+ve cells belonging to the CALB-SDN cluster
for this study. The identification and naming of the nuclei
was according to Paxinos and Franklin [22].
Stereology
The number of calbindin+ve neurons in both hemispheres
of each mouse was estimated using the principles of the
fractionator method [23]. The entire CALB-SDN was
examined on each section with a 0.75 numerical aperture
lens on a light microscope (Zeiss Axioplan, Oberkochen,Germany). To ensure that all calbindin+ve neurons in the
CALB-SDN were examined and to avoid double counting
errors, the position of each calbindin+ve neuron was traced
using a camera lucida. Calbindin+ve cells were excluded
from data collection when the perikaryon was cut at the
upper plane and included when intact or cut at the lower
plane of the sections. Every third consecutive section
was used for calbindin staining and cell counting. The
total number of calbindin+ve neurons in the CALB-SDN
was estimated by multiplying the number of cells counted
by three.
The sizes of the perikaryon of the calbindin+ve neurons
were measured using the direct moment estimation of the
volume of particles, which allows the unbiased estimation
of volume from single sections. The diameters of neurons
were measured in a random direction through a random
test-point with a 0.75 numerical aperture lens using the
camera lucida on a light microscope (Zeiss Axioplan). The
volumes were calculated with the estimator π/3 times the
diameter length l0 raised to the third power [23]. Approxi-
mately 20 cells per hemisphere of each animal were used
for the volumetric analysis and the mean size calculated for
each mouse.
The microscope slides were coded to blind the observer
(WW) to the sex and genotype of the mice. All presented
data are from the left hemisphere as no differences were
detected between the left and right hemispheres.
Statistics
Statistical calculations were undertaken with either
PASWstatistics18.0 (SPSS Inc, IBM, Armonk, NY, USA) or
GraphPad Prism software (www.graphpad.com). Data were
examined by two-way analysis of variance (ANOVA) for
(1) sex and genotype differences and (2) age and geno-
type differences. Significant effects were confirmed by
Student’s t test, with p values of <0.05 recorded in the
figures and tables.
Results
In the 20-day-old mice, there was a significant effect of sex
(p = 0.001, two-way ANOVA), Amh genotype (p = 0.008)
and sex × genotype interaction (p = 0.022) on the number
of calbindin+ve neurons in their CALB-SDN. The wild-
type 20-day-old pre-pubescent male mice had 47% more
calbindin+ve neurons in their CALB-SDN than their female
littermates (Figures 2 and 3A), but the size and general
appearance of the neurons were not overtly dimorphic
(Figures 2 and 4A). This initial sex difference was absent in
the Amh−/− mice, with the Amh−/− male mice containing
numbers of neurons that were no different to the female
mice (Figures 2 and 3A). The difference in the number of
neurons between the Amh+/+ and Amh−/− mice was highly
statistically significant (p = 0.004, Student’s t test; Figure 3A).
The size and appearance of the calbindin+ve neurons in the
Figure 2 The dimorphism in the CALB-SDN varies with age and Amh genotype. The images are photomicrographs of the CALB-SDN
illustrating the appearance of the nucleus in pre-pubescent (20 days old) and adult mice. All sections were stained with anti-calbindin antibodies.
The location of the CALB-SDN relative to the anterior commissure and third ventricle is illustrated in Figure 1, with the quantitative estimates of
the number and size of the calbindin+ve neurons illustrated in Figures 3 and 4, respectively. ♂, male; ♀, female.
Figure 3 The CALB-SDN has pre-pubescent and adult forms that are differentially regulated. The bars are the mean number of calbindin+ve
neurons ± the standard error of the mean of six mice. The Amh genotype (+/+ or −/−) is shown beneath each bar. (A) Twenty-day-old mice. *1:
There was a significant effect of sex (p = 0.001), genotype (p = 0.008) and sex × genotype interaction (p = 0.022, two-way ANOVA). *2: The Amh+/+
males were significantly different to Amh−/− males (p = 0.004) and both female groups (p < 0.002 Amh+/+, p < 0.001 Amh−/−, Student’s t test). (B)
Adult mice. *3: There was a significant effect of sex (p < 0.001), genotype (p = 0.002) and sex × genotype interaction (p = 0.003, two-way ANOVA). *4:
The Amh+/+ males were significantly different to all other adult groups (p = 0.002 to the Amh−/− males and p < 0.001 to both female groups,
Student’s t test). *5: The adult Amh−/− males were also significantly different to both of the adult female groups (p < 0.001 Amh+/+, p < 0.001 Amh−/−,
Student’s t test). (C) The bars illustrate the mean change in cell number after 20 days. In two-way ANOVAs of age and genotype, there was a
significant effect of age (p = 0.007) and genotype (p < 0.001) for the male mice and a significant effect of age (p < 0.001) for the female mice. The
adult mice were significantly different to the corresponding 20-day-old mice (p = 0.037 for the Amh+/+ males, p = 0.035 for the Amh+/+ females and
p = 0.017 for the Amh−/− females, Student’s t test). ♂, male; ♀, female.
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Figure 4 The size of neuronal soma in the CALB-SDN is dimorphic after puberty. The bars are the mean size of the cell body of the calbindin+ve
neurons ± the standard error of the mean of six mice. The Amh genotype (+/+ or −/−) is shown beneath each bar. (A) Twenty-day-old mice. There is no
effect of sex or genotype at this age. (B) Adult mice. *1: There was a significant effect of sex (p < 0.001, two-way ANOVA) but not of genotype. *2: The
Amh+/+ males were significantly different to both of the female groups (p = 0.005 Amh+/+ and p = 0.004 Amh−/−, Student’s t test). *3: The adult Amh−/−
males were also significantly different to both of the adult female groups (p = 0.011 Amh+/+, p = 0.008 Amh−/−, Student’s t test). (C) The bars illustrate
the mean change in cell size after 20 days. In the female mice, the change in size was marginally significant (p = 0.048, two-way ANOVA of age and
genotype). ♂, male; ♀, female.
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for both males and females (Figures 2 and 4A).
The CALB-SDN underwent multiple changes between
20 days and adulthood. The number of calbindin+ve neurons
increased slightly in the Amh+/+ male mice (Figure 3B,C)
and significantly decreased in the Amh+/+ female mice
(Figure 3B,C). This caused the mean male-to-female
ratio of neurons to increase from 1.47 (20 days) to 2.62
(adult). The male increase and female decrease in the
number of calbindin+ve neurons occurred in both the
Amh+/+ and Amh−/− mice (Figure 3C). Consequently, the
proportion of dimorphism that is attributable to AMH
decreased from approximately 100% at 20 days to 59%
in the adult. In a two-way ANOVA test, the number of
calbindin+ve neurons were significantly different, with re-
spect to sex (p < 0.001) and genotype (p = 0.002), with a
significant sex × genotype interaction (p = 0.003).
The size of the neuronal soma also became dimorphic
after 20 days of age, due to a slight hypertrophy in the
males and a slightly larger atrophy in the females (Figure 4).
The overall sex difference in the size of the calbindin+ve
neurons was, however, only 7%. As with neuronal number,
the change in the size of the neuronal soma was similar in
the Amh+/+ and Amh−/− mice (Figure 4C).
The appearance of the calbindin+ve neurons also be-
came dimorphic after 20 days, with the intensity of the
calbindin+ve immunoreactivity being consistently stronger in
the male than in the female mice (Figure 2). This was not
due to variation in the immunohistochemical procedure as
the brains were processed in groups of four, each of which
contained one female and one male brain of each genotype.This difference was independent of the Amh genotype
of the mice.
Discussion
The control of the number of the calbindin+ve neurons
in the murine CALB-SDN is biphasic, with both a pre-
pubertal phase and a phase that occurs after 20 days. These
two phases appear to involve different sex-specific inducers,
with the second phase involving changes in both female
and male mice.
Female puberty
In female mice, the number of calbindin+ve neurons in the
CALB-SDN decreased between 20 days and adulthood, in-
dicating that some of the neurons in the pre-pubescent
form of the nucleus either degenerated or differentiated
into another cell type. This is consistent with archival de-
scriptions of the SDN of the medial preoptic area in rats
(herein referred to as SDN), which showed a decrease in
the total volume of the nucleus in females between day 10
and adulthood [24]. A female-specific loss of neurons oc-
curs during puberty in the rat prefrontal cortex [5], raising
the possibility that pubescent loss of neurons may be a
broad feature of female brain development. If so, then this
would partially explain why the average size of the human
female brain decreases by over 10% during puberty [25].
Male puberty
The direction of pubescent change in the male CALB-SDN
was opposite to that in the females, with the number of
calbindin+ve neurons increasing after 20 days. This is
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strating the existence of gonadal-dependent neurogenesis
during puberty [4]. The magnitude of this increase was
similar in the Amh+/+ and Amh−/− mice, indicating that
the pubescent increase in the size of the male CALB-SDN
is independent of the pre-pubescent virilisation of the
nucleus by AMH (see below). This notwithstanding, the
number of calbindin+ve neurons in the CALB-SDN of
adult male Amh−/− mice was still less than that of the
Amh+/+ males, due to the different pre-pubescent devel-
opment of the Amh−/− and Amh+/+ mice. The functional
significance of this will depend on whether the AMH-
dependent and AMH-independent neurons in the CALB-
SDN have similar or distinct roles.
The current study was not designed to examine the
mechanism of the pubescent changes, only to detect
whether a change occurs after 20 days. The data presented
represent net changes. Consequently, neuronal loss, neuro-
genesis and/or change in cell type may be occurring in both
sexes, with a female bias to the reduction in calbindin+ve
neurons and a male bias to the increase in calbindin+ve neu-
rons. It is also possible that some neurons change from a
calbindin+ve to a calbindin−ve phenotype (or vice versa),
although this is unlikely to be a complete explanation for
the current data (Figures 3 and 4), given the rat observa-
tions noted above [4,24].
Pre-pubertal (‘childhood’) dimorphism and testosterone
imprinting
High dimorphic levels of testosterone are only transiently
present during development, with many features of the
male brain being induced during this period. Some of the
effects of testosterone during this period are mediated by
the androgen receptor, whereas other effects are mediated
by oestrogen receptors, after local aromatisation of testos-
terone [2]. The male features which develop between the
perinatal and pubescent surges of testosterone are puta-
tively generated by the prior exposure to testosterone.
We refer to this as testosterone imprinting. As detailed
below, the SDN of rats and the CALB-SDN in mice
are exemplifiers of imprinting through the actions of
aromatised testosterone. The dimorphism present in
the CALB-SDN immediately before the onset of pu-
berty (20 days) was absent in the Amh−/− mice, indi-
cating that most or all of this initial dimorphism is
dependent on AMH. The blood levels of testosterone
in Amh−/− male mice are therefore of interest.
AMH is a natural repressor of Leydig cell formation
[26] and a putative inhibitor of testosterone production
[27], with pathological elevation of AMH levels leading
to feminisation of mice, due to an apparent insufficiency
of testosterone [28]. Conversely, Amh−/− mice have an
extensive Leydig cell hyperplasia [29,30], which, in isola-
tion of other factors, should lead to increased levels oftestosterone and increased sexual dimorphism. However,
AMH also appears to negatively regulate the maturation
of Leydig cells [30], with the results that testosterone
levels in Amh−/− male mice are within the normal male
range [17,30,31], although data is not currently available for
either foetal or neonatal mice. The potency of a hormone
in vivo is regulated by binding proteins and other influ-
ences, with a biological readout of a hormone being
particularly important for this reason. The male features
of Amh−/− mice that develop during either the foetal/
neonatal or the pubertal surges of testosterone are quanti-
tatively normal [17,29]. Hence, in our view, the complete
absence of dimorphism in calbindin cell number in the
20-day-old mice is unlikely to be due to insufficient tes-
tosterone levels. This raises the possibility that AMH
and the sex steroids dually regulate the CALB-SDN
neurons (but see below). If so, then both AMH and tes-
tosterone may be needed to produce a male bias in the
number of calbindin+ve neurons.
Testosterone regulation of the neonatal SDN is pos-
tulated to involve local aromatisation of androgens to
oestrogens [21,32,33]. Consequently, the putative actions
of testosterone on this nucleus will be dependent on the
expression of aromatase in the CALB-SDN as well as the
plasma levels of testosterone. In this context, it will be im-
portant to determine whether the male bias in the expres-
sion of aromatase in the brain [34] is AMH dependent. If
so, then feminisation of the CALB-SDN in the Amh−/−
male pups could be secondary to diminished conversion
of testosterone to oestrogen.
Alternatively, the current results can be viewed as a
challenge to the concept of testosterone imprinting. The
non-dimorphic development of neurons are controlled
by multiple factors, each of which acts at a particular
stage of cell development (e.g. migration of the neuron,
initial axon outgrowth, dendritic branching, etc.). All of
these factors promote the survival of the neuron during
development, but only the target-derived factor controls
the number of neurons in the nucleus. When physiological
regulators of neurons are injected at times when they are
not normally present, then they mimic the action of
the endogenous (natural) regulator. Consequently, if the
physiological regulator of developmental cell death is added
when the neuron is extending an axon, the regulator
will promote axon outgrowth; conversely, if the physio-
logical regulator of axon outgrowth is added during
the period of cell death, then it will promote neuronal
survival (see [35] for a discussion of this). For this reason,
proof that a regulator is present at the time a cellular event
is occurring is one of the most important criteria to prove
the function of a non-dimorphic regulator of the brain
(neurotrophic theory [35,36]).
The initial sex difference in the number of SDN neurons
is created by a female bias in the extent of neuronal cell
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neonatal surge of testosterone, during the period when
the plasma levels of AMH but not testosterone are highly
dimorphic (cf. [21,37] and [11,39]). The low adult ovarian
production of AMH [13] is only beginning during this
period [40]. The homologous nucleus in humans also
develops when boys have high levels of AMH and only
female-like levels of testosterone (cf. [41] and [9,42]). Hence,
if neurotrophic theory is applicable, then this pattern of
hormone secretion is consistent with AMH regulating
the number of calbindin+ve neurons of the CALB-SDN
and is inconsistent with testosterone having this action.
All cytokine regulators of developing neurons leave a
lasting imprint on neuronal networks, yet testosterone is
the only regulator that is postulated to control neuronal
development through an imprinting mechanism. The con-
cept of testosterone imprinting was developed before the
existence of gonadal protein hormones was known, when
imprinting was the only apparent possibility for explaining
the importance of the gonads. The proof of imprinting is
predominantly based on experiments involving castration
and the injection of non-physiological levels of the sex
steroids into female mice. Castration removes testosterone,
but it also removes AMH and other gonadal protein
hormones (e.g. the inhibins [43-46]) that have dimorphic
aspects to their secretion. Experiments based on castration
are therefore open to multiple interpretations. Experiments
involving the administration of the sex steroids are similarly
open to debate for two reasons. First, the steroids have
typically been used at high concentrations, without
proof that the induced levels mirror the natural levels of
testosterone in developing males. Of particular concern
is whether steroids injected during the neonatal period
persist into the subsequent days when developing males
only have low levels of testosterone [11]. Second, both
the testes and the ovaries produce the same protein
hormones, but in different amounts and at different
times in the life cycle. AMH, for example, is the most
dimorphic of all the gonadal hormones during develop-
ment, but is only minimally dimorphic in young adults
[6,9-11]. Oestrogen and testosterone are paracrine regu-
lators of the ovary [47], with oestrogen being a putative
regulator of AMH production by ovarian granulosa cells
[48]. The effect of non-physiological administration of the
sex steroids on the secretion of protein hormones from
the immature ovary (and testes) is largely unknown. In the
absence of this information, any experiment involving a
manipulation of one gonadal hormone has a degree of
uncertainty because the effect on other hormones has
not been fully characterised. This uncertainty extends in
part to the current data. Hence, in our view, the concept
of testosterone imprinting is not yet robustly proven.
This alternative view does not argue against the import-
ance of the sex steroids. It simply suggests that the criteriaused to identify the non-dimorphic regulators of the brain
[35,36] are applicable to the study of the dimorphic regu-
lators of the brain. If so, the available evidence points to
testosterone regulating cellular events in the CALB-SDN
before and after the AMH-mediated regulation of cell
number. Non-dimorphic regulators of the brain have
different actions on different types of neurons. Hence, the
argument that AMH generates the male bias in neuron
number in the CALB-SDN (this manuscript) and other
neurons [14,17,49] is not an argument against testosterone
having a similar action on neurons in populations where
the control of cell number occurs during either the peri-
natal or the pubescent surges of testosterone.
Conclusions
The control of neuron number in the CALB-SDN appears
to be biphasic, with the different phases subject to different
regulation. One interpretation of this data is that organisa-
tion and activation events occur early in development and
during puberty, with the testicular influence being continu-
ous through direct non-imprinting effects of protein and
steroid hormones, acting at different times.
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